Tomographie par émission de positons et cancers digestifs
| Autor: | Emmanuel Touboul, Philippe Ruszniewski, Khaldoun Kerrou, Dany Grahek, Jean-Didier Grangé, Fabrice Gutman, Françoise Montravers, Philippe Rougier, Houry S, Raoul Poupon, Thierry André, Jean-Noël Talbot, Olivier Rosmorduc, Virginie Huchet |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Oncology
medicine.medical_specialty medicine.diagnostic_test business.industry Pet imaging medicine.disease Biliary cancer Somatostatin Positron emission tomography Hepatocellular carcinoma Internal medicine medicine General Earth and Planetary Sciences Endocrine system Recurrent Colorectal Cancer Molecular imaging business General Environmental Science |
| Zdroj: | La Presse Médicale. 37:e1-e24 |
| ISSN: | 0755-4982 |
| DOI: | 10.1016/j.lpm.2007.03.048 |
| Popis: | In digestive oncology, the most frequent indication for FDG PET, in our experience and as reported in the literature, is the localisation of recurrent colorectal cancer. This molecular imaging method has also been shown to be clinically useful in various other settings, especially for preoperative staging, for colorectal, esophageal, gastric, pancreatic, hepatic and biliary cancers. We also report on current PET practice in two particular cancers: hepatocellular carcinoma, for which other tracers, including fluoromethylcholine-(18F), are being currently evaluated, and gastrointestinal endocrine tumours, which are included in the recent French marketing authorisation of fluoroDOPA-(18F) and which are also potential targets for radiolabelled somatostatin analogues for PET imaging. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect